Home › Pheochromocytoma › Maryland › Baltimore
Pheochromocytoma clinical trials in Baltimore, MD
3 studies for Pheochromocytoma are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
- Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Developmental Therapeutics ( Site 0108), Baltimore
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Johns Hopkins, Baltimore
About Pheochromocytoma
Pheochromocytoma is a rare tumor. Pheochromocytomas often cause the adrenal gland to make too many hormones. This can lead to high blood pressure.
More about Pheochromocytoma on MedlinePlus
Pheochromocytoma trials in other cities
- Washington, DC9 studies
- Cedar Rapids, IA3 studies
- Los Angeles, CA3 studies
- Nashville, TN3 studies
- Chicago, IL3 studies
- Philadelphia, PA3 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Bladder Cancer24 studies
- Heart Failure24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.